Pharm-Olam International Ltd. (POI) will open an additional U.S. office in Princeton, NJ this November.
"With the opening of our Princeton office, Pharm-Olam is even better positioned to serve the needs of pharma and biotech sponsors in the Eastern U.S.", said Iain Gordon, vice president of global business development. "Although Pharm-Olam has been known for its work in ex-U.S. markets, we are experiencing rapid growth of our U.S.-based operations and decided to open a second office to complement our headquarters in Houston. We continue to hire experienced staff throughout North America to meet the increasing demand of sponsors wanting to conduct Canadian and U.S. trials.
POI provides a range of clinical research services to the pharmaceutical, biotechnology and medical device industries, from pre-clinical to Phase IV.